Market cap
₹70 Cr
Revenue (TTM)
₹25 Cr
P/E Ratio
18.2
P/B Ratio
1.8
Div. Yield
0 %
Quality Score
5/10
Growth Score
9/10
Valuation Score
6/10
Momentum Score
3/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹4 Cr
-
ROE
50.6 %
-
ROCE
42.6 %
-
Industry P/E
49.21
-
EV/EBITDA
13.9
-
Debt to Equity
0.7
-
Book Value
₹17.1
-
EPS
₹6.9
-
Face value
10
-
Shares outstanding
8,512,360
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Asston Pharmaceuticals
| 0.0 | 7.5 | 10.0 | -- | -- | -- | -- |
|
BSE Healthcare*
| 8.8 | 0.1 | 10.4 | 7.4 | 23.8 | 13.3 | 12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Asston Pharmaceuticals
|
82.5 | 70.3 | 25.0 | 4.3 | -- | 50.6 | 18.2 | 1.8 |
| 1,051.2 | 12,906.7 | 2,551.8 | 564.5 | 28.3 | 18.4 | 22.9 | 3.9 | |
| 504.3 | 8,749.6 | 947.3 | 247.8 | 28.5 | 18.9 | 35.3 | 6.4 | |
| 1,380.2 | 14,448.0 | 1,054.9 | 256.3 | 27.8 | 13.7 | 55.4 | 7.2 | |
| 1,705.6 | 32,327.5 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35 | 6.5 | |
| 17,056.0 | 21,873.6 | 2,023.0 | 364.0 | 23.9 | 20.8 | 60.1 | 11.7 | |
| 960.9 | 4,872.1 | 811.3 | 21.0 | 0.7 | 2.1 | 237.1 | 3.8 | |
| 1,283.2 | 5,904.3 | 649.5 | 121.6 | 23.7 | 13.2 | 51.2 | 6.3 | |
| 822.6 | 9,295.7 | 502.0 | 138.7 | -- | 32.8 | 53.8 | 10.5 | |
| 269.9 | 7,112.5 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 12.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Asston Pharmaceuticals
--
-
Incorporated
2019
-
Chairman
--
-
Managing Director
Ashish Narayan Sakalkar
-
Headquarters
Thane, Maharashtra
-
Website
Looking for more details about Asston Pharmaceuticals Ltd’s IPO? Explore our IPO Details page.
Annual Reports
FAQs for Asston Pharmaceuticals
What is the current share price of Asston Pharmaceuticals Ltd Today?
The share price of Asston Pharmaceuticals Ltd is ₹82.53 (BSE) as of 15-Jun-2026 IST. Asston Pharmaceuticals Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Asston Pharmaceuticals Ltd?
The P/E ratio of Asston Pharmaceuticals Ltd is 18.18 times as on 15-Jun-2026, a 63 discount to its peers’ median range of 49.21 times.
The P/B ratio of Asston Pharmaceuticals Ltd is 1.84 times as on 15-Jun-2026, a 64 discount to its peers’ median range of 5.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
What is the 52 Week High and Low of Asston Pharmaceuticals Ltd?
The 52-week high and low of Asston Pharmaceuticals Ltd are Rs 126.00 and Rs 61.02 as of 16-Jun-2026.
What is the market cap of Asston Pharmaceuticals Ltd?
Asston Pharmaceuticals Ltd has a market capitalisation of ₹ 70 Cr as on 15-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Asston Pharmaceuticals Ltd?
Before investing in Asston Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.